We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Phorm Corp | LSE:PHRM | London | Ordinary Share | SG9999009278 | ORD NPV (DI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 1.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Jul 2019 to Jul 2024
TIDMPHRM
RNS Number : 9140X
Phorm Corporation Limited
17 January 2014
17 January 2014
Phorm Corporation Limited ("Phorm" or the "Company")
AIM Rule 17 Disclosure Schedule Two (g) Update
Phorm (AIM: PHRM), a leading internet personalisation technology company, announces, in accordance with Rule 17 and Schedule Two (g) sub-paragraph (v) of the AIM Rules for Companies, that it has been notified of the following information by Lord Norman Lamont, Non-Executive Director of Phorm:
Lord Lamont was, until 19 October 2012, a director of Balli Group Plc ("Balli"), a private company incorporated in the UK. Balli was placed into administration on 20 March 2013 and Deloitte LLP were appointed as administrators.
In addition, Lord Lamont was, until 30 March 2009, a director of Pantin Hotels (Management) Limited, a private company incorporated in the UK, subsequently renamed Hallco 1063 Limited ("Hallco") on 7 May 2009. Hallco entered into a creditors' voluntary liquidation on 24 July 2009 with an estimated total deficit as regards creditors on that date of GBP116,438. Hallco was dissolved on 14 January 2011.
-ends-
Contact
Phorm Corporation Limited
Andy Croxson (analysts & investors) +44 20 3397 6001
UK Investors
Mirabaud Securities LLP +44 20 7321 2508 (Joint Broker)
Jason Woollard
Peter Krens
Liberum Capital +44 20 3100 2222 (Nominated Advisor and Joint Broker)
Chris Bowman
Richard Bootle
US Investors
Lippert Heilshorn and Associates +1 212 838 3777 (Investor Relations)
John Heilshorn
About Phorm
Phorm is a global personalisation technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience.
Phorm's industry leading technology enables its ISP partners to offer a new type of online advertising platform and a free consumer internet content feature, ensuring more relevant advertisements and personalised content for opted-in users.
Phorm's advertising platform revolutionises current standards of online privacy, fully protecting the identity of consumers. Unlike virtually all other targeted advertising propositions, Phorm's solution is completely opt-in. Only those users consenting to the service are profiled and only ever on an anonymous basis.
Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Advertising Networks and Advertisers.
Phorm, under a predecessor holding company, was admitted to the AIM market of the London Stock Exchange in 2004.
For more information, please visit: www.phorm.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCSFFSIWFLSEEF
1 Year Phorm Corp Chart |
1 Month Phorm Corp Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
